Slow Capital’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Slow Capital’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-745	Closed	-$18K	–	173
2023 Q1	$18K	Buy	+745	New	+$9.35K	﹤0.01%	151

Other funds holding PRVB

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Slow Capital's PRVB Position: Q2 2023 in Review

Slow Capital sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 745 shares — an estimated $18K sold.

Slow Capital first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $18K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Slow Capital reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Slow Capital sold 745 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $18K.
Slow Capital first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Slow Capital's Provention Bio, Inc. Common Stock position peaked at $18K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Slow Capital's 13F filing for Q2 2023, filed 9 Aug 2023.